Consensus Alcon Inc. Tradegate

Stocks

2U3

CH0432492467

Medical Equipment, Supplies & Distribution

Real-time Tradegate 05:05:21 28/08/26 pm AEST			5-day change	1st Jan Change
62.14 ^EUR	+0.19%		-0.67%	-9.19%

27/08	Alcon Prices Public Offering of EUR500 Million Senior Notes Due 2033	MT
27/08	Alcon Prices Senior Notes due 2033	MT

Evolution of the Average Target: Alcon Inc.

Evolution of the Target Price: Alcon Inc.

Changes in Analyst Recommendations: Alcon Inc.

139be287543d.y56GxQ2uVmZgN1rMocPiyWWUpp-M7WBFYE9Vgurijo4.uqn28mGcFQMWbiK22e7Uvwui9u7doyE0DSo08JPTw_ulzP6GNfcaHgJgDw~e15b8ff2cde26e884781bc2133963f47

Analysts' recommendations: Alcon Inc.

17/08	Deutsche Bank raises TP for Alcon, but shares down
13/08	BNP Paribas Downgrades Alcon to Neutral, Cuts PT	MT
13/08	Bernstein Updates Alcon Estimates, Price Target After 'Strong' Commercial Execution in Q2	MT
12/08	Alcon: Q2 story: Innovation is being well received by the end market
25/05	Baptista Research Upgrades Alcon to Buy Rating	MT
13/05	Swiss Market Index Closes Higher; SoftwareOne Shares Jump	MT
08/05	Bernstein Keeps Alcon at Outperform After Q1 Results; Estimates, Price Target Revised	MT
07/05	Needham Trims Price Target on Alcon to $95 From $100, Keeps Buy Rating	MT
07/05	Alcon: Results weren't bad; today's correction is a buying opportunity
06/05	Alcon Price Target Declines as AlphaValue/Baader Cuts Estimates on Rising Competition, Expenses	MT
06/05	Swiss stocks - Factors to watch on May 6	RE
06/05	Alcon: Investment case hinges on profitability expansion
21/04	RBC Bullish on Alcon's FY26 Growth Outlook; Outperform Maintained	MT
20/03	AlphaValue/Baader Europe Upgrades Alcon to Add Rating, Lifts PT	MT
16/03	Bernstein: Risk in Alcon's Implantables Business 'Manageable,' Already Priced In	MT
10/03	Bernstein Says Alcon Top Pick in European Medtech Coverage, Notes 'Good Momentum' for Key Products into FY26	MT
06/03	Berenberg Keeps Alcon at Buy Amid Signs of US Cataract Market Rebound	MT
04/03	Alcon Kept at Outperform as RBC Notes 'Positive Setup' Through FY26; Estimates Revised	MT
27/02	Equita SIM Upgrades Alcon to Buy, Raises PT	MT
27/02	Needham Raises Price Target on Alcon to $100 From $98, Keeps Buy Rating	MT
27/02	Wells Fargo Upgrades Alcon AG to Overweight From Equal Weight, Adjusts PT to $97 From $88	MT
26/02	Alcon Estimates Tweaked as Bernstein Notes Potential Upside from End-market Recovery; Price Target Up	MT
26/02	Alcon: Markets forgive Q4 miss for a healthy 2026 outlook
18/02	RBC Updates Alcon Estimates Ahead of FY25 Earnings; Outperform Rating Kept	MT
11/02	RBC Expects Alcon's Upcoming FY26 Guidance to Drive Share Price Volatility; Outperform Rating Kept	MT

More recommendations

Glasses, Spectacles & Contact Lenses

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ESSILORLUXOTTICA					+54.48%
	ALCON INC.					+25.63%
	THE COOPER COMPANIES, INC.					+14.85%
	LENSKART SOLUTIONS LIMITED					+4.16%
	SHANGHAI CONANT OPTICAL CO., LTD.					+40.33%
	AUTEK CHINA INC.					+27.75%
	PEGAVISION CORPORATION					+6.82%
	MINGYUE OPTICAL LENS CO.,LTD.					+38.05%
	SPYGLASS PHARMA, INC.					+63.39%
	Average					+30.61%
	Weighted average by Cap.					+39.48%